impact of co-morbidities
role of co-morbidities
different co-morbidities
definition co-morbidities
leading HCC
impact HCC pathogenesis
management of HCC
HCC immunobiology
co-morbidity specific disease pathways
host pathways
HEP-CAR
European Liver Patients Association
cellular pathways
European Association
liver diseases
common liver malignancy
hepatitis B
NASH
drivers of host oncogenic pathways
needed pre-clinical models
C infection
hepatocellular carcinoma pathogenesis
European citizens
higher incidence
mortality
aim of HEP
Study
art tissue explant models
novel humanized mouse models
C virus infection
treatment failure
year of diagnosis
treatment responses
clinical excellence
new cases
new approaches
communication competence of leading organizations
mechanistic studies
lipidomic screens
understanding
nonalcoholic steatohepatitis
increasing public health problem
individualized therapy
knowledge transfer
sustained improvements
future drug screening
deaths
prevention
state
EASL
heterogeneous nature
rating
Mechanisms
ELPA
tumour
women
cancers
gender
established patient cohorts
research
world